Assertio Holdings | DEPO - Ebit

Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $-3.94M in EBIT for its fiscal quarter ending in September of 2023.





Ebit Change Date
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 6.62B 1.51B Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Omeros USD -48.15M 7.25M Sep/2023
Pfizer USD 4.65B 71M Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025